<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Vet Med Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Vet. Med. Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JVMS</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Veterinary Medical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0916-7250</issn>
      <issn pub-type="epub">1347-7439</issn>
      <publisher>
        <publisher-name>The Japanese Society of Veterinary Science</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24646602</article-id>
      <article-id pub-id-type="pmc">4143645</article-id>
      <article-id pub-id-type="publisher-id">13-0315</article-id>
      <article-id pub-id-type="doi">10.1292/jvms.13-0315</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Internal Medicine</subject>
          <subj-group>
            <subject>Note</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Case of Gastric Adenocarcinoma in a Shih Tzu Dog: Successful Treatment of
Early Gastric Cancer</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>LEE</surname>
            <given-names>Hee-Chun</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>KIM</surname>
            <given-names>Ji-Hyun</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>JEE</surname>
            <given-names>Cho-Hee</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>LEE</surname>
            <given-names>Jae-Hoon</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>MOON</surname>
            <given-names>Jong-Hyun</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>KIM</surname>
            <given-names>Na-Hyun</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>SUR</surname>
            <given-names>Jung-Hyang</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>CHO</surname>
            <given-names>Kyu-Woan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>KANG</surname>
            <given-names>Byeong-Teck</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>HA</surname>
            <given-names>Jeongim</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>JUNG</surname>
            <given-names>Dong-In</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref rid="cor1" ref-type="corresp">
            <sup>*</sup>
          </xref>
        </contrib>
        <aff id="aff1"><label>1)</label>Research Institute of Life Sciences, College of Veterinary
Medicine, Gyeongsang National University, Jinju 660&#x2013;701, South Korea</aff>
        <aff id="aff2"><label>2)</label>Department of Pathobiology, Small Animal Tumor Diagnostic
Center, College of Veterinary Medicine, Konkuk University, Seoul 143&#x2013;701, South
Korea</aff>
        <aff id="aff3"><label>3)</label>Laboratory of Veterinary Dermatology and Neurology, College
of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, 361&#x2013;763, South
Korea</aff>
        <aff id="aff4"><label>4)</label>Department of Cell and Developmental Biology, School of
Dentistry, DRI and Brain Korea 21 Program, Seoul National University, Seoul 110&#x2013;749, South
Korea</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>*</label>Correspondence to: Jung D.-I., Research Institute of Life
Sciences, College of Veterinary Medicine, Gyeongsang National University, Jinju 660&#x2013;701,
South Korea. e-mail: <email xlink:href="jungdi@gnu.ac.kr">jungdi@gnu.ac.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>3</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>7</month>
        <year>2014</year>
      </pub-date>
      <volume>76</volume>
      <issue>7</issue>
      <fpage>1033</fpage>
      <lpage>1038</lpage>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>6</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>3</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2014 The Japanese Society of Veterinary Science</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p>
        </license>
      </permissions>
      <abstract>
        <title>ABSTRACT</title>
        <p>A 9-year-old castrated male Shih Tzu dog was referred to us, because of chronic
vomiting. The patient&#x2019;s hematological, radiographic, ultrasonographic, endoscopic and
histological examinations were evaluated for diagnosis. Hematologic analysis indicated
moderate anemia and azotemia. Based on the imaging studies, an oval-shaped mass was
identified in the gastric pylorus area. A proliferative mass was found on endoscopic
examination, and we performed biopsy using grasping forceps. The histopathological
findings of the biopsy specimens indicated hypertrophic gastritis, and Y-U pyloroplasty
was performed. However, histopathological examination of the surgically resected mass
revealed tubular adenocarcinoma of the stomach. Then, carboplatin chemotherapy was
performed 4 times for 13 weeks. Clinical signs, such as vomiting, were resolved gradually
after surgery and chemotherapy, and the patient&#x2019;s condition was managed favorably until
recently (30 months after surgery). This case report describes clinical features, imaging
studies, endoscopic characteristics and histopathological and immunohistochemical features
of gastric tubular adenocarcinoma as early gastric cancer in a dog.</p>
      </abstract>
      <kwd-group>
        <kwd>adenocarcinoma</kwd>
        <kwd>canine</kwd>
        <kwd>early gastric cancer (EGC)</kwd>
        <kwd>gastric hyperplasia</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Tumors of the canine gastrointestinal (GI) tract are uncommon and account for less than 1% of
all reported neoplasms [<xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r10" ref-type="bibr">10</xref>, <xref rid="r36" ref-type="bibr">36</xref>]. Evidence for the etiology
of canine gastric tumor has not been defined until now [<xref rid="r10" ref-type="bibr">10</xref>]. Malignant gastric tumors have been reported more than benign tumors, followed
by adenocarcinoma, leiomyosarcoma, lymphoma, leiomyoma and adenoma. Adenocarcinoma is the most
common gastric malignancy in dogs, comprising 47 to 73% of all gastric tumors [<xref rid="r12" ref-type="bibr">12</xref>, <xref rid="r14" ref-type="bibr">14</xref>, <xref rid="r28" ref-type="bibr">28</xref>, <xref rid="r31" ref-type="bibr">31</xref>]. The World
Health Organization (WHO) classifies gastric carcinomas in domestic animals, dividing them
into 5 types: tubular carcinoma, mucinous carcinoma, signet ring cell carcinoma,
undifferentiated carcinoma and papillary carcinoma [<xref rid="r13" ref-type="bibr">13</xref>]. The prognosis of adenocarcinoma is mostly guarded, and most studies of this tumor
type report that the majority of patients survive less than 6 months [<xref rid="r2" ref-type="bibr">2</xref>, <xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r10" ref-type="bibr">10</xref>, <xref rid="r15" ref-type="bibr">15</xref>].</p>
    <p>This case report describes clinical features, imaging studies, endoscopic characteristics and
histopathological features of canine tubular adenocarcinoma of the stomach in a dog.</p>
    <p>A 9-year-old castrated male Shih Tzu dog presented with a history of chronic vomiting and
episodic melena. According to the case history, vomiting sign was observed 8 months before
presentation. A GI protectant was administered at a local animal hospital, and no neoplastic
changes were found on GI endoscopy. Since moderate anemia (hematocrit: 25%) was identified
based on a complete blood count, erythropoietin was given to the patient at the local animal
hospital. The patient was referred to us, because the chronic vomiting and anemia were not
resolved after management at the local animal hospital. At the time of initial presentation,
moderate to severe anemia (hematocrit: 19.6%) and increased alkaline phosphatase and blood
urea nitrogen were revealed in a blood analysis (alkaline phosphatase, 743
U/<italic>l</italic> [reference range; 20&#x2013;150 U/<italic>l</italic>]; blood urea nitrogen, 76
mg/d<italic>l</italic> [reference range; 7&#x2013;25
mg/d<italic>l</italic>]). The survey abdominal radiographs showed distension of the stomach,
accumulation of gas in the esophagus and a soft tissue opacity mass, which was summated with
the gastric pylorus (<xref ref-type="fig" rid="fig_001">Fig. 1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p>Survey lateral abdominal radiography shows (A) the presence of a well-defined, smooth,
oval-shaped mass with soft tissue opacity overlapped with the stomach caudal to the
liver and (B) enhancement of the soft tissue opacity at the cranial and middle regions
of the abdomen and distension of the stomach with food, with the stomach deviating
laterally and being positioned vertically.</p></caption><graphic xlink:href="jvms-76-1033-g001"/></fig>). Abdominal ultrasonography showed an oval-shaped mass of mixed echogenicity in the
gastric pylorus, which was surrounded by thickend muscularis layers and gastric dilation with
fluid and food (<xref ref-type="fig" rid="fig_002">Fig. 2</xref><fig orientation="portrait" fig-type="figure" id="fig_002" position="float"><label>Fig. 2.</label><caption><p>Abdominal ultrasonography shows (A) vascular flow of the pyloric region in the Doppler
test, (B) the presence of thickening of the gastric wall and (C) no pyloric obstruction
in postoperative abdominal ultrasonography. (D) Fourteen months after surgery, a
decrease in gastric wall thickness can be seen.</p></caption><graphic xlink:href="jvms-76-1033-g002"/></fig>). In a color Doppler test, the muscularis layers exhibited vascular flow. These gastric
changes were considered to indicate a gastric neoplasm.</p>
    <p>A gastrointestinal endoscopic examination was performed, and a proliferative mass was found
in the pyloric outflow tract (<xref ref-type="fig" rid="fig_003">Fig. 3A</xref><fig orientation="portrait" fig-type="figure" id="fig_003" position="float"><label>Fig. 3.</label><caption><p>Serial endoscopic findings of the present patient. (A) Obstruction of the pyloric
region by a proliferative mass was identified in the initial examination. (B) Several
endoscopic biopsy samples were obtained from the lesion. (C) Five months after surgery,
occlusion of the pyloric region was resolved. (D) Nineteen-months after surgery, the
pylorus was open, and there were no ulcerative or hemorrhagic lesions.</p></caption><graphic xlink:href="jvms-76-1033-g003"/></fig><fig orientation="portrait" fig-type="figure" id="fig_004" position="float"><label>Fig. 4.</label><caption><p>Resection of the mass and Y-U pyloroplasty. (A) Intraoperative photograph showing the
mass at the pyloric region after gastrotomy (arrows). (B) Resection of the mass is
complete. The defect was closed by re-opposing the mucosa and submucosa with the
Cushging pattern. (C) The resected mass of the pyloric area. The margin of the mass,
including the mucosa and part of the submucosa layer, was peeled off the pylorus. (D) A
completed Y-U antral advanced flap.</p></caption><graphic xlink:href="jvms-76-1033-g004"/></fig>). Multiple biopsy samples were taken with grasping forceps (<xref ref-type="fig" rid="fig_003">Fig. 3B</xref>), and the histopathological results for these specimens
indicated hypertrophic gastritis (<xref ref-type="fig" rid="fig_005">Fig. 5A</xref><fig orientation="portrait" fig-type="figure" id="fig_005" position="float"><label>Fig. 5.</label><caption><p>Histopathological results of endoscopic biopsy specimens (A) and surgically resected
specimens (B, C, D, E, F, G and H). Panels A, B, C and D show hematoxylin and eosin
staining features. Panels E, F and G show CDX-2 immunohistochemical features of
surgically resected specimens. Panel H shows p53 immunohistochemical features of
surgically resected specimens. (A) A high power image shows the involved gastric pit
(crypts), which contains enlarged hyperchromatic nuclei that became crowded nuclei
(scale bar: 32 <italic>&#xB5;</italic>m). (B) The gastric lesion is composed of well-formed
tubules, some of which are cystically dilated (scale bar: 467 <italic>&#xB5;</italic>m). (C
and D) Intestinal type (tubular type) gastric adenocarcinoma formed by glands with
various degrees of differentiation (scale bar: 47 <italic>&#xB5;</italic>m). (E and F) CDX-2
expression in a moderately differentiated tubular type of canine gastric adenocarcinoma.
High power images show strong nuclear expressions of CDX-2 in moderately differentiated
tumor cells in the present patient (scale bar: 32 <italic>&#xB5;</italic>m). (G and H)
Moderate expression of nuclear staining for Ki-67 seen in the present patient (scale
bar: 47 <italic>&#xB5;</italic>m).</p></caption><graphic xlink:href="jvms-76-1033-g005"/></fig>). Then, we performed marginal resection of the tumor and a Y-U pyloroplasty (<xref ref-type="fig" rid="fig_004">Fig. 4</xref>). After the surgery, the patient was given
partial parenteral nutrition therapy for 10 days, because of vomiting. Eleven days after the
surgery, the patient was allowed the liquid food, and clinical signs were gradually alleviated
including vomiting and diarrhea.</p>
    <p>The histologic results for the surgically resected masses indicated intestinal type (tubular
type) gastric adenocarcinoma. The gastric adenocarcinoma was formed by glands with various
degrees of differentiation (<xref ref-type="fig" rid="fig_005">Fig. 5C and 5D</xref>). The
gastric lesion was composed of well-formed tubules, some of which were cystically dilated
(<xref ref-type="fig" rid="fig_005">Fig. 5B</xref>). Based on the histopathological
findings, we strongly suspected gastric adenocarcinoma. To confirm our tentative diagnosis, we
performed additional immunohistochemistry to evaluate the expression of CDX-2 (Abcam,
Cambridge, MA, U.S.A.) and Ki-67 (Clone MIB-1, Dako, Glostrup, Denmark). Sections were placed
in a 65&#xB0;C oven for 20 min, dewaxed and rehydrated through xylene and graded ethanol solutions
to phosphate buffered saline (PBS; pH 7.4, 0.1 M). Endogenous peroxidase was blocked by
incubating the sections in 3% H<sub>2</sub>0<sub>2</sub> in PBS for 20 min at room temperature
(RT). After three washes in PBS, antigens were retrieved by heating in citrate buffer (pH 6.0)
for 20 min in a microwave oven (650 W at high power). Each section was then overlaid with
primary antibodies to CDX-2 (1:200) or Ki-67 (1:300) diluted in PBS. Sections were incubated
with primary reagent at 4&#xB0;C overnight and then washed in PBS three times. EnVision system-HRP
(DakoCytomation, Carpinteria, CA, U.S.A.) was applied for detection of binding of primary
reagents. Sections were counterstained with Harris&#x2019;s hematoxylin, dehydrated and coverslipped
under Permount&#x2122; (Fisher Scientific, Fair Lawn, NJ, U.S.A.). Intense nuclear CDX-2 expression
was noted in moderately differentiated tumor cells (<xref ref-type="fig" rid="fig_005">Fig. 5E
and 5F</xref>). Moderate expression of nuclear staining for Ki-67 was seen in tumor cells
(<xref ref-type="fig" rid="fig_005">Fig. 5G and 5H</xref>). The expression of Ki-67 was
partially positive, indicating that the tumor cells had progressed to a malignant form. Based
on the histopathological and immunohistochemical findings, this case was definitively
diagnosed as an early stage canine gastric adenocarcinoma.</p>
    <p>Unfortunately, marginal resection of the tumor and Y-U pyloroplasty had been performed based
on the endoscopic biopsy results (hypertrophic gastritis), and we could not be confident that
all cancer cells had been removed during the surgery. Therefore, we decided to treat with
carboplatin chemotherapy (Carbotinol<sup>&#xAE;</sup>, Korea United Pharm., Seoul, South Korea; 250
mg/m<sup>2</sup> for the first injection and then 200 mg/m<sup>2</sup> 3 times during 10 weeks). Then, we regularly
performed hematologic, radiographic and ultrasonographic examinations to evaluate the dog for
metastasis or recurrence of the cancer. We performed thoracic and abdominal computed
tomographic (CT) examinations 2 times after surgery (5 and 11 months after surgery), and the
results were normal. Furthermore, gastrointestinal endoscopic examinations were performed
again, and there were no remarkable findings (<xref ref-type="fig" rid="fig_003">Fig. 3C and
3D</xref>). The status of the patient was well controlled until recently (more than 30
months after surgery).</p>
    <p>Canine carcinoma is the most common gastric neoplasm in the dog [<xref rid="r9" ref-type="bibr">9</xref>, <xref rid="r24" ref-type="bibr">24</xref>]. The WHO classifies this
malignancy in domestic animals based on the growth pattern of the carcinoma, but the relation
between the histological type and other characteristics associated with the prognosis has not
been previously reported [<xref rid="r2" ref-type="bibr">2</xref>, <xref rid="r13" ref-type="bibr">13</xref>]. Carcinoma of the canine stomach may arise in any part of the stomach.
Canine gastric carcinomas can assume a wide range of forms, but they mostly have the features
of tubular adenocarcinoma. This case was a mucosa form and was diagnosed as intestinal type
(tubular type) canine gastric adenocarcinoma.</p>
    <p>The diagnosis of gastric neoplasms is usually based on clinical features and imaging findings
and is confirmed by histopathological and immunohistochemical examinations [<xref rid="r19" ref-type="bibr">19</xref>]. Endoscopy is a useful definitive diagnostic
investigation for observing the size, location and morphology of a tumor and for obtaining
biopsy samples [<xref rid="r10" ref-type="bibr">10</xref>, <xref rid="r20" ref-type="bibr">20</xref>]. In humans, over 90% of tumor cases can be diagnosed by endoscopy [<xref rid="r14" ref-type="bibr">14</xref>]. In the present case, the histologic result for the
endoscopic forceps biopsy specimens was hypertrophic gastritis, but the result for the
surgically resected specimens was gastric tubular adenocarcinoma. Interestingly, histologic
discrepancies have been reported for gastric cancer between endoscopic forceps biopsy and
surgical endoscopic treatment sample in human medicine with the incidence ranging from 25 to
35% [<xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r25" ref-type="bibr">25</xref>].
According to one report of human gastric cancer, this discrepancy is found frequently in early
gastric cancer (EGC). EGC is defined as adenocarcinoma confined to the mucosa or submucosa,
irrespective of lymph node involvement, in human medicine [<xref rid="r9" ref-type="bibr">9</xref>]. Because endoscopy cannot detect diseases that primarily involve the submucosal,
muscularis or serosal layers of the stomach and the size of the biopsy sample is restricted by
the cup size [<xref rid="r20" ref-type="bibr">20</xref>], EGC may not be identified with this
procedure. Based on these studies, the gastric tumor in the present case could be thought of
as equivalent to EGC in humans. The gastric tumor in the present patient was restricted to the
mucosal and submucosal areas, and there was no metastasis to other organs or lymph nodes.
Furthermore, there were sessile nodules of mucosal proliferation instead of ulcerative,
hemorrhage and infiltrative lesions which are seen in most cases of adenocarcinoma on
endoscopy.</p>
    <p>CDX-2 is an intestine-specific homeobox product that plays a key role in the regulation,
proliferation and differentiation of intestinal epithelial cells during normal embryonic and
postnatal development. CDX-2 is known as an important nuclear transcription factor that
regulates development of intestinal metaplasia and gastric carcinogenesis [<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r21" ref-type="bibr">21</xref>, <xref rid="r32" ref-type="bibr">32</xref>, <xref rid="r35" ref-type="bibr">35</xref>]. According
to previous reports [<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r16" ref-type="bibr">16</xref>, <xref rid="r22" ref-type="bibr">22</xref>, <xref rid="r27" ref-type="bibr">27</xref>, <xref rid="r35" ref-type="bibr">35</xref>], CDX-2 is strongly associated with
the intestinal phenotypic expression in gastric carcinomas.</p>
    <p>One recent veterinary report [<xref rid="r5" ref-type="bibr">5</xref>] demonstrated that all
canine gastric adenocarcinomas in the study expressed CDX-2 and that 86.4% of the colorectal
adenocarcinomas expressed CDX-2. Interestingly, that report [<xref rid="r5" ref-type="bibr">5</xref>] indicated that CDX-2 expression was detected in the normal canine colorectal
mucosa, but was not found in the normal canine gastric mucosa. Based on those study results
[<xref rid="r5" ref-type="bibr">5</xref>], CDX-2 expression could be useful for the
diagnosis of canine gastric adenocarcinoma, as it was not detected in the normal canine
gastric epithelium. One other report suggested CDX-2 expression was increased in gastric
carcinomas with less invasiveness and an intestinal phenotype, but CDX-2 expression was
decreased in advanced gastric carcinomas [<xref rid="r16" ref-type="bibr">16</xref>]. Strong
nuclear expressions of CDX-2 in moderately differentiated tumor cells were noticed in the
present patient. However, Whether or not CDX-2 is expressed in nonneoplastic conditions, e.g.
hypertrophic gastritis, is unknown, although the normal gastric mucosa is almost negative.</p>
    <p>Thus, we performed Ki-67 immunohistochemistry as proliferative marker for evaluating
malignancy in the present patient. According to previous reports [<xref rid="r18" ref-type="bibr">18</xref>, <xref rid="r23" ref-type="bibr">23</xref>], Ki-67 is a nonhistone
protein with expression that peaks during G2/M, so tumors with a higher proliferation rate
demonstrate greater Ki-67 expression. In the present patient, positive Ki-67 expression was
detected in tumor cells, and this suggested a malignant tumor of the gastric mucosa.</p>
    <p>Therefore, the immunohistochemistry results for CDX-2 and Ki-67 could support the diagnosis
of early stage gastric adenocarcinoma (early gastric cancer) in the present patient.</p>
    <p>Surgery is the only potentially effective treatment for localized canine gastric carcinoma
[<xref rid="r10" ref-type="bibr">10</xref>, <xref rid="r24" ref-type="bibr">24</xref>], and
partial gastrectomy is usually indicated for this malignancy [<xref rid="r7" ref-type="bibr">7</xref>]. Generally, the prognosis after surgery is poor, and most affected dogs expired
within 6 months of diagnosis [<xref rid="r3" ref-type="bibr">3</xref>]. In several studies
that described the prognosis of surgical treatment for canine adenocarcinoma, the median
survival time was only 55 days for 29 dogs treated with surgery. [<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r10" ref-type="bibr">10</xref>, <xref rid="r33" ref-type="bibr">33</xref>]. In human cases, endoscopic submucosal dissection or surgical resection
is indicated for EGC [<xref rid="r17" ref-type="bibr">17</xref>]. In the present case, we
performed surgical submucosal resection of the mass and Y-U pyloroplasty for obstruction of
the pyloric outflow tract based on the initial histopathological results. We then initiated
chemotherapy since identified malignant change of the mass. According to one study in humans,
adjuvant chemotherapy was effective for prevention of postoperative recurrence in patients
with EGC [<xref rid="r30" ref-type="bibr">30</xref>]. In human stomach tumor, chemotherapy is
effective as an adjuvant therapy followed by surgical resection, improving overall survival
[<xref rid="r26" ref-type="bibr">26</xref>, <xref rid="r29" ref-type="bibr">29</xref>].
Carboplatin chemotherapy for adenocarcinoma is controversial these days, but carboplatin has
been shown to have an antitumor effect in human gastric tumor cells and animal models of
gastric tumor [<xref rid="r1" ref-type="bibr">1</xref>]. Furthermore, carboplatin had marginal
activity in patients with gastric cancer, with response rates of 6&#x2013;10% as a single agent
[<xref rid="r29" ref-type="bibr">29</xref>, <xref rid="r34" ref-type="bibr">34</xref>]. In
the present case, we used 250 mg/m<sup>2</sup> carboplatin for the first injection and then
used 200 mg/m<sup>2</sup> for the 3 subsequent treatments. Despite the fact that this type of
tumor is known to have a guarded prognosis, the status of the patient has been well controlled
after treatment (30 months after surgery).</p>
    <p>In conclusion, this report describes the clinical features and prognosis of a canine tubular
type gastric adenocarcinoma treated with surgical resection and chemotherapy. We suggest the
possibility that a gastric tumor similar to EGC in humans could exist in dogs. This report is
the first report of a human EGC-like gastric tumor in dogs. Therefore, more cases of suspected
EGC in dogs should be studied in an attempt to investigate this type of tumor.</p>
  </body>
  <back>
    <ack>
      <p>This research was supported by the Basic Science Research Program through
the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science
and Technology (2011-0008358).</p>
    </ack>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Beer</surname><given-names>M.</given-names></name><name><surname>Cavalli</surname><given-names>F.</given-names></name><name><surname>Kaye</surname><given-names>S. B.</given-names></name><name><surname>Lev</surname><given-names>L. M.</given-names></name><name><surname>Clavel</surname><given-names>M.</given-names></name><name><surname>Smyth</surname><given-names>J.</given-names></name></person-group><year>1987</year>
<article-title>A phase II study of carboplatin in
advanced or metastatic stomach cancer</article-title>. <source><italic>Eur. J. Cancer
Clin. Oncol.</italic></source><volume>23</volume>:
<fpage>1565</fpage>&#x2013;<lpage>1567</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0277-5379(87)90101-5</pub-id><pub-id pub-id-type="pmid">3315695</pub-id></mixed-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Carrasco</surname><given-names>V.</given-names></name><name><surname>Canfr&#xE1;n</surname><given-names>S.</given-names></name><name><surname>Rodr&#xED;guez-Franco</surname><given-names>F.</given-names></name><name><surname>Benito</surname><given-names>A.</given-names></name><name><surname>S&#xE1;inz</surname><given-names>A.</given-names></name><name><surname>Rodr&#xED;guez-Bertos</surname><given-names>A.</given-names></name></person-group><year>2011</year>
<article-title>Canine gastric carcinoma;
Immunohistochemical expression of cell cycle proteins (p53, p21, and p16) and heat shock
proteins (Hsp27 and Hsp70)</article-title>. <source><italic>Vet.
Pathol.</italic></source><volume>48</volume>: <fpage>322</fpage>&#x2013;<lpage>329</lpage>.
doi: <pub-id pub-id-type="doi">10.1177/0300985810375050</pub-id><pub-id pub-id-type="pmid">20587688</pub-id></mixed-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Nielsen</surname><given-names>C.</given-names></name><name><surname>Anderson</surname><given-names>G. M.</given-names></name></person-group><year>2005</year>
<article-title>Metastasis of gastric adenocarcinoma to
the abdominal wall following placement of a gastrostomy tube in a dog</article-title>.
<source><italic>Can. Vet. J.</italic></source><volume>46</volume>:
<fpage>641</fpage>&#x2013;<lpage>643</lpage>
<pub-id pub-id-type="pmid">16152722</pub-id></mixed-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Crow</surname><given-names>S. E.</given-names></name></person-group><year>1985</year>
<article-title>Tumors of the alimentary
tract</article-title>. <source><italic>Vet. Clin. North Am. Small Anim.
Pract.</italic></source><volume>15</volume>: <fpage>577</fpage>
<pub-id pub-id-type="pmid">3892870</pub-id></mixed-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Doster</surname><given-names>A. R.</given-names></name><name><surname>Yhee</surname><given-names>J. Y.</given-names></name><name><surname>Kim</surname><given-names>J. H.</given-names></name><name><surname>Im</surname><given-names>K. S.</given-names></name><name><surname>Sur</surname><given-names>J. H.</given-names></name></person-group><year>2011</year>
<article-title>CDX-2 and HER-3 expression in canine
gastric and colorectal adenocarcinomas</article-title>. <source><italic>J. Comp.
Pathol.</italic></source><volume>145</volume>: <fpage>12</fpage>&#x2013;<lpage>19</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/j.jcpa.2010.11.007</pub-id><pub-id pub-id-type="pmid">21238975</pub-id></mixed-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Elliott</surname><given-names>G. S.</given-names></name><name><surname>Stoffregen</surname><given-names>D. A.</given-names></name><name><surname>Richardson</surname><given-names>D. C.</given-names></name><name><surname>Blevins</surname><given-names>W. E.</given-names></name><name><surname>Richardson</surname><given-names>R. C.</given-names></name></person-group><year>1984</year>
<article-title>Surgical, medical, and nutritional
management of gastric adenocarcinoma in a dog</article-title>. <source><italic>J. Am.
Vet. Med. Assoc.</italic></source><volume>185</volume>:
<fpage>98</fpage>&#x2013;<lpage>101</lpage>
<pub-id pub-id-type="pmid">6430849</pub-id></mixed-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Fossum</surname><given-names>T. W.</given-names></name><name><surname>Hedlund</surname><given-names>C. S.</given-names></name></person-group><year>2003</year>
<article-title>Gastric and intestinal
surgery</article-title>. <source><italic>Vet. Clin. North Am. Small Anim.
Pract.</italic></source><volume>33</volume>: <fpage>1117</fpage>&#x2013;<lpage>1145</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/S0195-5616(03)00053-6</pub-id><pub-id pub-id-type="pmid">14552164</pub-id></mixed-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Fonda</surname><given-names>D.</given-names></name><name><surname>Gualtieri</surname><given-names>M.</given-names></name><name><surname>Scanziani</surname><given-names>E.</given-names></name></person-group><year>1989</year>
<article-title>Gastric carcinoma in the dog;
clinicopathological study of 11cases</article-title>. <source><italic>J. Small Anim.
Pract.</italic></source><volume>30</volume>: <fpage>353</fpage>&#x2013;<lpage>360</lpage>.
doi: <pub-id pub-id-type="doi">10.1111/j.1748-5827.1989.tb01579.x</pub-id></mixed-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Goldstein</surname><given-names>N. S.</given-names></name><name><surname>Lewin</surname><given-names>K. J.</given-names></name></person-group><year>1997</year>
<article-title>Gastric epithelial dysplasia and adenoma:
historical review and histological criteria for grading</article-title>.
<source><italic>Hum. Pathol.</italic></source><volume>28</volume>:
<fpage>127</fpage>&#x2013;<lpage>133</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0046-8177(97)90095-2</pub-id><pub-id pub-id-type="pmid">9023391</pub-id></mixed-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Gualtieri</surname><given-names>M.</given-names></name><name><surname>Monzeglio</surname><given-names>M. G.</given-names></name><name><surname>Scanziani</surname><given-names>E.</given-names></name></person-group><year>1999</year>
<article-title>Gastric Neoplasia</article-title>.
<source><italic>Vet. Clin. North Am. Small Anim.
Pract.</italic></source><volume>29</volume>: <fpage>415</fpage>&#x2013;<lpage>440</lpage>
<pub-id pub-id-type="pmid">10202797</pub-id></mixed-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Hansson</surname><given-names>L. E.</given-names></name><name><surname>Lindgren</surname><given-names>A.</given-names></name><name><surname>Nyr&#xE9;n</surname><given-names>O.</given-names></name></person-group><year>1996</year>
<article-title>Can endoscopic biopsy specimens be used
for reliable Laur&#xE9;n classification of gastric
cancer?</article-title><source><italic>Scand. J.
Gastroenterol.</italic></source><volume>31</volume>:
<fpage>711</fpage>&#x2013;<lpage>715</lpage>. doi: <pub-id pub-id-type="doi">10.3109/00365529609009155</pub-id><pub-id pub-id-type="pmid">8819223</pub-id></mixed-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Hayden</surname><given-names>D. W.</given-names></name><name><surname>Nielsen</surname><given-names>S. W.</given-names></name></person-group><year>1973</year>
<article-title>Canine Alimentary
Neoplasia</article-title>. <source><italic>Zentralbl. Veterinarmed.
A</italic></source><volume>20</volume>: <fpage>1</fpage>&#x2013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1439-0442.1973.tb00859.x</pub-id><pub-id pub-id-type="pmid">4196657</pub-id></mixed-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Head</surname><given-names>K.W.</given-names></name><name><surname>Cullen</surname><given-names>J.M.</given-names></name><name><surname>Dubielzig</surname><given-names>R.R.</given-names></name><name><surname>Else</surname><given-names>R.W.</given-names></name><name><surname>Misdorp</surname><given-names>W.</given-names></name><name><surname>Patnaik</surname><given-names>A.K.</given-names></name><name><surname>Tateyama</surname><given-names>S.</given-names></name><name><surname>Van Der. Gaag</surname><given-names>I.</given-names></name></person-group><year>2003</year> Histological Classification of Tumors of the Alimentary
System of Domestic Animals, 2nd Series, vol. IX. Armed Forces Institute of Pathology,
Washington, D.C.</mixed-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>McLoughlin</surname><given-names>J. M.</given-names></name></person-group><year>2004</year>
<article-title>Adenocarcinoma of the stomach: a
review</article-title>. <source><italic>Proc. (Bayl. Univ. Med.
Cent.)</italic></source>.<volume>17</volume>: <fpage>391</fpage>&#x2013;<lpage>399</lpage>
<pub-id pub-id-type="pmid">16200126</pub-id></mixed-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Kapatkin</surname><given-names>A. S.</given-names></name><name><surname>Mullen</surname><given-names>H. S.</given-names></name><name><surname>Matthien</surname><given-names>D. T.</given-names></name><name><surname>Patnaik</surname><given-names>A. K.</given-names></name></person-group><year>1992</year>
<article-title>Leiomyosarcoma in dogs: 44 cases
(1983&#x2013;1988)</article-title>. <source><italic>J. Am. Vet. Med.
Assoc.</italic></source><volume>201</volume>: <fpage>1077</fpage>&#x2013;<lpage>1079</lpage>
<pub-id pub-id-type="pmid">1429139</pub-id></mixed-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Kim</surname><given-names>G. H.</given-names></name><name><surname>Song</surname><given-names>G. A.</given-names></name><name><surname>Park</surname><given-names>D. Y.</given-names></name><name><surname>Lee</surname><given-names>S. H.</given-names></name><name><surname>Lee</surname><given-names>D. H.</given-names></name><name><surname>Kim</surname><given-names>T. O.</given-names></name><name><surname>Jo</surname><given-names>H. J.</given-names></name><name><surname>Heo</surname><given-names>J.</given-names></name><name><surname>Kang</surname><given-names>D. H.</given-names></name><name><surname>Cho</surname><given-names>M.</given-names></name></person-group><year>2006</year>
<article-title>CDX2 expression is increased in gastric
cancers with less invasiveness and intestinal mucin phenotype</article-title>.
<source><italic>Scand. J. Gastroenterol.</italic></source><volume>41</volume>:
<fpage>880</fpage>&#x2013;<lpage>886</lpage>. doi: <pub-id pub-id-type="doi">10.1080/00365520500497140</pub-id><pub-id pub-id-type="pmid">16803685</pub-id></mixed-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Kim</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>S. H.</given-names></name><name><surname>Park</surname><given-names>W. H.</given-names></name><name><surname>Jang</surname><given-names>J. S.</given-names></name><name><surname>Bang</surname><given-names>J. S.</given-names></name><name><surname>Yang</surname><given-names>S. H.</given-names></name><name><surname>Byun</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>Y. J.</given-names></name></person-group><year>2012</year>
<article-title>Predictable factors of histologic
discrepancy of gastric cancer between the endoscopic forceps biopsy and endoscopic
treatment specimen</article-title>. <source><italic>Korean J.
Gastroenterol.</italic></source><volume>59</volume>:
<fpage>354</fpage>&#x2013;<lpage>359</lpage>. doi: <pub-id pub-id-type="doi">10.4166/kjg.2012.59.5.354</pub-id><pub-id pub-id-type="pmid">22617529</pub-id></mixed-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Landberg</surname><given-names>G.</given-names></name><name><surname>Tan</surname><given-names>E. M.</given-names></name><name><surname>Roos</surname><given-names>G.</given-names></name></person-group><year>1990</year>
<article-title>Flow cytometric multiparameter analysis
of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: a new view of the cell
cycle</article-title>. <source><italic>Exp. Cell
Res.</italic></source><volume>187</volume>: <fpage>111</fpage>&#x2013;<lpage>118</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/0014-4827(90)90124-S</pub-id><pub-id pub-id-type="pmid">1967582</pub-id></mixed-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Lee</surname><given-names>H. C.</given-names></name><name><surname>Kwon</surname><given-names>D. H.</given-names></name><name><surname>Moon</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>Y. K.</given-names></name><name><surname>Cho</surname><given-names>K. W.</given-names></name><name><surname>Kang</surname><given-names>B. T.</given-names></name><name><surname>Im</surname><given-names>K. S.</given-names></name><name><surname>Sur</surname><given-names>J. H.</given-names></name><name><surname>Jung</surname><given-names>D. I.</given-names></name></person-group><year>2012</year>
<article-title>Gastric Adenoma in the Pyloric Outflow
Tract of a Shih-tzu Dog. <italic>J. Vet</italic></article-title>.
<source><italic>Clin.</italic></source><volume>29</volume>:
<fpage>169</fpage>&#x2013;<lpage>172</lpage></mixed-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Moore</surname><given-names>L. E.</given-names></name></person-group><year>2003</year>
<article-title>The advantages and disadvantages of
endoscopy</article-title>. <source><italic>Clin. Tech. Small Anim.
Pract.</italic></source><volume>18</volume>: <fpage>250</fpage>&#x2013;<lpage>253</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/S1096-2867(03)00071-9</pub-id><pub-id pub-id-type="pmid">14738206</pub-id></mixed-citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Mallo</surname><given-names>G. V.</given-names></name><name><surname>Soubeyran</surname><given-names>P.</given-names></name><name><surname>Lissitzky</surname><given-names>J. C.</given-names></name><name><surname>Andr&#xE9;</surname><given-names>F.</given-names></name><name><surname>Farnarier</surname><given-names>C.</given-names></name><name><surname>Marvaldi</surname><given-names>J.</given-names></name><name><surname>Dagorn</surname><given-names>J. C.</given-names></name><name><surname>Iovanna</surname><given-names>J. L.</given-names></name></person-group><year>1998</year>
<article-title>Expression of the Cdx1 and Cdx2 homeotic
genes leads to reduced malignancy in colon cancer-derived cells</article-title>.
<source><italic>J. Biol. Chem.</italic></source><volume>273</volume>:
<fpage>14030</fpage>&#x2013;<lpage>14036</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.273.22.14030</pub-id><pub-id pub-id-type="pmid">9593754</pub-id></mixed-citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Mazziotta</surname><given-names>R. M.</given-names></name><name><surname>Borczuk</surname><given-names>A. C.</given-names></name><name><surname>Powell</surname><given-names>C. A.</given-names></name><name><surname>Mansukhani</surname><given-names>M.</given-names></name></person-group><year>2005</year>
<article-title>CDX2 immunostaining as a gastrointestinal
marker: expression in lung carcinomas is a potential pitfall</article-title>.
<source><italic>Appl. Immunohistochem. Mol.
Morphol.</italic></source><volume>13</volume>: <fpage>55</fpage>&#x2013;<lpage>60</lpage>. doi:
<pub-id pub-id-type="doi">10.1097/00129039-200503000-00009</pub-id><pub-id pub-id-type="pmid">15722794</pub-id></mixed-citation>
      </ref>
      <ref id="r23">
        <label>23</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Morris</surname><given-names>J. S.</given-names></name><name><surname>Nixon</surname><given-names>C.</given-names></name><name><surname>King</surname><given-names>O. J.</given-names></name><name><surname>Morgan</surname><given-names>I. M.</given-names></name><name><surname>Philbey</surname><given-names>A. W.</given-names></name></person-group><year>2009</year>
<article-title>Expression of TopBP1 in canine mammary
neoplasia in relation to histological type, Ki67, ER&#x3B1; and p53</article-title>.
<source><italic>Vet. J.</italic></source><volume>179</volume>:
<fpage>422</fpage>&#x2013;<lpage>429</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tvjl.2007.10.025</pub-id><pub-id pub-id-type="pmid">18314357</pub-id></mixed-citation>
      </ref>
      <ref id="r24">
        <label>24</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Ogilvie</surname><given-names>G.K.</given-names></name><name><surname>Moore</surname><given-names>A.S.</given-names></name></person-group><year>1995</year> Managing the Veterinary Cancer Patient: A Practice
Manual, Veterinary Learning System, Trenton.</mixed-citation>
      </ref>
      <ref id="r25">
        <label>25</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Palli</surname><given-names>D.</given-names></name><name><surname>Bianchi</surname><given-names>S.</given-names></name><name><surname>Cipriani</surname><given-names>F.</given-names></name></person-group><year>1991</year>
<article-title>Reproducibility of histologic
classification of gastric cancer</article-title>. <source><italic>Br. J.
Cancer</italic></source><volume>63</volume>: <fpage>765</fpage>&#x2013;<lpage>768</lpage>. doi:
<pub-id pub-id-type="doi">10.1038/bjc.1991.171</pub-id><pub-id pub-id-type="pmid">2039701</pub-id></mixed-citation>
      </ref>
      <ref id="r26">
        <label>26</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Paoletti</surname><given-names>X.</given-names></name><name><surname>Oba</surname><given-names>K.</given-names></name><name><surname>Burzykowski</surname><given-names>T.</given-names></name><name><surname>Michiels</surname><given-names>S.</given-names></name><name><surname>Ohashi</surname><given-names>Y.</given-names></name><name><surname>Pignon</surname><given-names>J. P.</given-names></name><name><surname>Rougier</surname><given-names>P.</given-names></name><name><surname>Sakamoto</surname><given-names>J.</given-names></name><name><surname>Sargent</surname><given-names>D.</given-names></name><name><surname>Sasako</surname><given-names>M.</given-names></name><name><surname>Van</surname><given-names>C. E.</given-names></name><name><surname>Buyse</surname><given-names>M.</given-names></name></person-group><year>2010</year>
<article-title>Benefit of Adjuvant Chemotherapy for
Resectable Gastric Cancer: A meta-analysis</article-title>.
<source><italic>JAMA</italic></source><volume>303</volume>:
<fpage>1729</fpage>&#x2013;<lpage>1737</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2010.534</pub-id><pub-id pub-id-type="pmid">20442389</pub-id></mixed-citation>
      </ref>
      <ref id="r27">
        <label>27</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Park</surname><given-names>Y.</given-names></name><name><surname>Srivastava</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>G. H.</given-names></name><name><surname>Mino-Kenudson</surname><given-names>M.</given-names></name><name><surname>Deshpande</surname><given-names>V.</given-names></name><name><surname>Zukerberg</surname><given-names>L. R.</given-names></name><name><surname>Song</surname><given-names>G. A.</given-names></name><name><surname>Lauwers</surname><given-names>G. Y.</given-names></name></person-group><year>2010</year>
<article-title>CDX2 expression in the intestinal-type
gastric epithelial neoplasia: frequency and significance</article-title>.
<source><italic>Mod. Pathol.</italic></source><volume>23</volume>:
<fpage>54</fpage>&#x2013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1038/modpathol.2009.135</pub-id><pub-id pub-id-type="pmid">19820687</pub-id></mixed-citation>
      </ref>
      <ref id="r28">
        <label>28</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Patnaik</surname><given-names>A. K.</given-names></name><name><surname>Hurvitz</surname><given-names>A. I.</given-names></name><name><surname>Johnson</surname><given-names>G. F.</given-names></name></person-group><year>1977</year>
<article-title>Canine gastrointestinal
neoplasms</article-title>. <source><italic>Vet.
Pathol.</italic></source><volume>14</volume>: <fpage>547</fpage>&#x2013;<lpage>555</lpage>
<pub-id pub-id-type="pmid">579266</pub-id></mixed-citation>
      </ref>
      <ref id="r29">
        <label>29</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Preusser</surname><given-names>P.</given-names></name><name><surname>Wilke</surname><given-names>H.</given-names></name><name><surname>Achterrath</surname><given-names>W.</given-names></name><name><surname>Lenaz</surname><given-names>L.</given-names></name><name><surname>Stahl</surname><given-names>M.</given-names></name><name><surname>Casper</surname><given-names>J.</given-names></name></person-group><year>1990</year>
<article-title>Phase II study of carboplatin in
untreated inoperable advanced stomach cancer</article-title>. <source><italic>Eur. J.
Cancer</italic></source><volume>26</volume>: <fpage>1108</fpage>&#x2013;<lpage>1109</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/0277-5379(90)90067-4</pub-id><pub-id pub-id-type="pmid">2148891</pub-id></mixed-citation>
      </ref>
      <ref id="r30">
        <label>30</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Sasaki</surname><given-names>A.</given-names></name></person-group><year>1994</year>
<article-title>Effect of adjuvant chemotherapy for
patients with early gastric cancer</article-title>. <source><italic>Gan To Kagaku
Ryoho</italic></source><volume>21</volume>: <fpage>37</fpage>&#x2013;<lpage>45</lpage>
<pub-id pub-id-type="pmid">8291914</pub-id></mixed-citation>
      </ref>
      <ref id="r31">
        <label>31</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Sautter</surname><given-names>J. H.</given-names></name><name><surname>Hanlon</surname><given-names>G. F.</given-names></name></person-group><year>1975</year>
<article-title>Gastric Neoplasms in the Dog: a report of
20 cases</article-title>. <source><italic>J. Am. Vet. Med.
Assoc.</italic></source><volume>166</volume>: <fpage>691</fpage>&#x2013;<lpage>696</lpage>
<pub-id pub-id-type="pmid">1173578</pub-id></mixed-citation>
      </ref>
      <ref id="r32">
        <label>32</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Silberg</surname><given-names>D. G.</given-names></name><name><surname>Swain</surname><given-names>G. P.</given-names></name><name><surname>Suh</surname><given-names>E. R.</given-names></name><name><surname>Traber</surname><given-names>P. G.</given-names></name></person-group><year>2000</year>
<article-title>Cdx1 and cdx2 expression during
intestinal development</article-title>.
<source><italic>Gastroenterology</italic></source><volume>119</volume>:
<fpage>961</fpage>&#x2013;<lpage>971</lpage>. doi: <pub-id pub-id-type="doi">10.1053/gast.2000.18142</pub-id><pub-id pub-id-type="pmid">11040183</pub-id></mixed-citation>
      </ref>
      <ref id="r33">
        <label>33</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Swann</surname><given-names>H. M.</given-names></name><name><surname>Holt</surname><given-names>D. E.</given-names></name></person-group><year>2002</year>
<article-title>Canine Gastric Adenocarcinoma and
leiomyosarcoma; a retrospective study of 21 cases (1986&#x2013;1999) and literature
review</article-title>. <source><italic>J. Am. Anim. Hosp.
Assoc.</italic></source><volume>38</volume>: <fpage>157</fpage>&#x2013;<lpage>164</lpage>
<pub-id pub-id-type="pmid">11908834</pub-id></mixed-citation>
      </ref>
      <ref id="r34">
        <label>34</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Takahashi</surname><given-names>H.</given-names></name><name><surname>Sasaki</surname><given-names>Y.</given-names></name><name><surname>Saijo</surname><given-names>N.</given-names></name><name><surname>Sakurai</surname><given-names>M.</given-names></name><name><surname>Nakano</surname><given-names>H.</given-names></name><name><surname>Nakagawa</surname><given-names>K.</given-names></name><name><surname>Hoshi</surname><given-names>A.</given-names></name><name><surname>Jett</surname><given-names>J. R.</given-names></name><name><surname>Hong</surname><given-names>W. S.</given-names></name></person-group><year>1987</year>
<article-title><italic>In vitro</italic> colony
inhibition of carboplatin against stomach and lung cancer cell lines in comparison with
cisplatin</article-title>. <source><italic>Cancer Chemother.
Pharmacol.</italic></source><volume>19</volume>: <fpage>197</fpage>&#x2013;<lpage>200</lpage>.
doi: <pub-id pub-id-type="doi">10.1007/BF00252972</pub-id><pub-id pub-id-type="pmid">3034444</pub-id></mixed-citation>
      </ref>
      <ref id="r35">
        <label>35</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Werling</surname><given-names>R. W.</given-names></name><name><surname>Yaziji</surname><given-names>H.</given-names></name><name><surname>Bacchi</surname><given-names>C. E.</given-names></name><name><surname>Gown</surname><given-names>A. M.</given-names></name></person-group><year>2003</year>
<article-title>CDX2, a highly sensitive and specific
marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476
primary and metastatic carcinomas</article-title>. <source><italic>Am. J. Surg.
Pathol.</italic></source><volume>27</volume>: <fpage>303</fpage>&#x2013;<lpage>310</lpage>.
doi: <pub-id pub-id-type="doi">10.1097/00000478-200303000-00003</pub-id><pub-id pub-id-type="pmid">12604886</pub-id></mixed-citation>
      </ref>
      <ref id="r36">
        <label>36</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Withrow</surname><given-names>S.J.</given-names></name></person-group><year>2007</year> Gastric cancer. pp. 480&#x2013;483. <italic>In:</italic>
Withrow &amp; MacEwen&#x2019;s Small Aminal clinical oncology, 4th ed. (Withrow, S.J. and Vail,
D.M., eds.), Saunders, Philadelphia.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
